Norgalax (Docusate Sodium)

Docusate Sodium is a surfactant laxative that acts locally in the colon to relieve constipation.

• Occasional constipation: softens stool to facilitate regular bowel movements in individuals experiencing infrequent bowel habits.
• Functional constipation: reduces stool hardness, helping patients with chronic bowel motility issues achieve smoother evacuation.
• Constipation related to reduced fluid intake: enhances water retention in the stool, mitigating hardness caused by dehydration.

• Docusate sodium acts as a surfactant that lowers the surface tension of intestinal contents. By inserting its hydrophilic and lipophilic groups at the stool–water interface, it allows water and fatty acids to penetrate the fecal mass, increasing moisture content and softening consistency. This facilitates peristaltic activity and promotes easier passage of stool through the rectum without stimulating intestinal motility.

Docusate sodium may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Abdominal cramping
• Mild diarrhea
• Rectal irritation or burning
• Nausea
• Flatulence

Serious or Rare Side Effects

• Allergic reaction (rash, itching, swelling)
• Severe abdominal pain
• Rectal bleeding
• Electrolyte imbalance with prolonged high‑dose use
• Severe dehydration

When using Norgalax, consider the following precautions to ensure safe and effective therapy.

• Assess bowel function: confirm that constipation is not due to obstruction before initiating therapy.
• Avoid use in complete bowel obstruction: docusate does not resolve mechanical blockage.
• Use with caution in inflammatory bowel disease: monitor for worsening symptoms.
• Monitor fluid intake: adequate hydration supports stool softening.
• Limit duration of use: prolonged use may lead to dependence or electrolyte disturbances.
• Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Docusate sodium can interact with certain medications, affecting their absorption or efficacy.

Major Interactions (Avoid)

• Mineral oil: may coat stool and reduce docusate’s surfactant effect.
• Oral antacids: can interfere with docusate absorption when taken simultaneously.
• Other laxatives (e.g., stimulant laxatives): combined use increases risk of electrolyte imbalance and dehydration.

Moderate Interactions (Monitor Closely)

• Oral medications requiring rapid absorption (e.g., certain antibiotics): may experience delayed uptake if taken with docusate.
• Anticoagulants: monitor for any changes in bleeding risk, although interaction is uncommon.